Back to mobile site

Medicines Co. (MDCO) Misses Q4 EPS by 1c

February 27, 2019 7:15 AM EST

Medicines Co. (NASDAQ: MDCO) reported Q4 EPS of ($0.62), $0.01 worse than the analyst estimate of ($0.61). Revenue for the quarter came in at $0 , versus $8.6 million reported last year.

For earnings history and earnings-related data on Medicines Co. (MDCO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings